Skip to main content
Erschienen in: European Radiology 2/2011

01.02.2011 | Gastrointestinal

Derivation of a T2-weighted MRI total colonic inflammation score (TCIS) for assessment of patients with severe acute inflammatory colitis—a preliminary study

verfasst von: Rehana Hafeez, Shonit Punwani, Doug Pendse, Paul Boulos, Stuart Bloom, Steve Halligan, Stuart A. Taylor

Erschienen in: European Radiology | Ausgabe 2/2011

Einloggen, um Zugang zu erhalten

Abstract

Objective

To derive an MRI score for assessing severity, therapeutic response and prognosis in acute severe inflammatory colitis.

Methods

Twenty-one patients with acute severe colitis underwent colonic MRI after admission and again (n = 16) after median 5 days of treatment. Using T2-weighted images, two radiologists in consensus graded segmental haustral loss, mesenteric and mural oedema, mural thickness, and small bowel and colonic dilatation producing a total colonic inflammatory score (TCIS, range 6–95). Pre- and post-treatment TCIS were compared, and correlated with CRP, stool frequency, and number of inpatient days (therapeutic response marker). Questionnaire assessment of patient worry, satisfaction and discomfort graded 1 (bad) to 7 (good) was administered

Results

Admission TCIS correlated significantly with CRP (Kendall’s tau=0.45, 95% confidence interval [CI] 0.11–0.79, p = 0.006), and stool frequency (Kendall’s tau 0.39, 95% CI 0.14-0.64, p = 0.02). TCIS fell after treatment (median [22 range 15–31]) to median 20 [range 8–25], p = 0.01. Admission TCIS but not CRP or stool frequency was correlated with length of inpatient stay (Kendall’s tau 0.40, 95% CI 0.11–0.69, p = 0.02). Patients reported some discomfort (median score 4) during MRI.

Conclusions

MRI TCIS falls after therapy, correlates with existing markers of disease severity, and in comparison may better predict therapeutic response.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Caprilli R, Latella G, Vernia P, Frieri G (2000) Multiple organ dysfunction in ulcerative colitis. Am J Gastroenterol 95:1258–1262CrossRefPubMed Caprilli R, Latella G, Vernia P, Frieri G (2000) Multiple organ dysfunction in ulcerative colitis. Am J Gastroenterol 95:1258–1262CrossRefPubMed
2.
Zurück zum Zitat Brown SR, Haboubi N, Hampton J, George B, Travis SP (2008) The management of acute severe colitis: ACPGBI position statement. Colorectal Dis 10(Suppl 3):8–29CrossRefPubMed Brown SR, Haboubi N, Hampton J, George B, Travis SP (2008) The management of acute severe colitis: ACPGBI position statement. Colorectal Dis 10(Suppl 3):8–29CrossRefPubMed
3.
Zurück zum Zitat D’Haens G, Lemmens L, Geboes K et al (2001) Intravenous cyclosporine versus intravenous corticosteroids as single therapy for severe attacks of ulcerative colitis. Gastroenterology 120:1323–1329CrossRefPubMed D’Haens G, Lemmens L, Geboes K et al (2001) Intravenous cyclosporine versus intravenous corticosteroids as single therapy for severe attacks of ulcerative colitis. Gastroenterology 120:1323–1329CrossRefPubMed
4.
Zurück zum Zitat Jakobovits SL, Jewell DP, Travis SP (2007) Infliximab for the treatment of ulcerative colitis: outcomes in Oxford from 2000 to 2006. Aliment Pharmacol Ther 25:1055–1060CrossRefPubMed Jakobovits SL, Jewell DP, Travis SP (2007) Infliximab for the treatment of ulcerative colitis: outcomes in Oxford from 2000 to 2006. Aliment Pharmacol Ther 25:1055–1060CrossRefPubMed
5.
Zurück zum Zitat Jakobovits SL, Travis SP (2005) Management of acute severe colitis. Br Med Bull 75–76:131–144PubMed Jakobovits SL, Travis SP (2005) Management of acute severe colitis. Br Med Bull 75–76:131–144PubMed
6.
7.
Zurück zum Zitat Katz JA (2000) Medical and surgical management of severe colitis. Semin Gastrointest Dis 11:18–32PubMed Katz JA (2000) Medical and surgical management of severe colitis. Semin Gastrointest Dis 11:18–32PubMed
8.
Zurück zum Zitat Vermeire S, Van AG, Rutgeerts P (2004) C-reactive protein as a marker for inflammatory bowel disease. Inflamm Bowel Dis 10:661–665CrossRefPubMed Vermeire S, Van AG, Rutgeerts P (2004) C-reactive protein as a marker for inflammatory bowel disease. Inflamm Bowel Dis 10:661–665CrossRefPubMed
9.
Zurück zum Zitat Travis SP, Farrant JM, Ricketts C et al (1996) Predicting outcome in severe ulcerative colitis. Gut 38:905–910CrossRefPubMed Travis SP, Farrant JM, Ricketts C et al (1996) Predicting outcome in severe ulcerative colitis. Gut 38:905–910CrossRefPubMed
10.
Zurück zum Zitat Vermeire S, Van AG, Rutgeerts P (2006) Laboratory markers in IBD: useful, magic, or unnecessary toys? Gut 55:426–431CrossRefPubMed Vermeire S, Van AG, Rutgeerts P (2006) Laboratory markers in IBD: useful, magic, or unnecessary toys? Gut 55:426–431CrossRefPubMed
11.
Zurück zum Zitat Ajaj W, Goyen M (2007) MR imaging of the colon: “technique, indications, results and limitations”. Eur J Radiol 61:415–423CrossRefPubMed Ajaj W, Goyen M (2007) MR imaging of the colon: “technique, indications, results and limitations”. Eur J Radiol 61:415–423CrossRefPubMed
13.
Zurück zum Zitat Schreyer AG, Scheibl K, Heiss P, Feuerbach S, Seitz J, Herfarth H (2006) MR colonography in inflammatory bowel disease. Abdom Imaging 31:302–307CrossRefPubMed Schreyer AG, Scheibl K, Heiss P, Feuerbach S, Seitz J, Herfarth H (2006) MR colonography in inflammatory bowel disease. Abdom Imaging 31:302–307CrossRefPubMed
14.
Zurück zum Zitat Ajaj WM, Lauenstein TC, Pelster G et al (2005) Magnetic resonance colonography for the detection of inflammatory diseases of the large bowel: quantifying the inflammatory activity. Gut 54:257–263CrossRefPubMed Ajaj WM, Lauenstein TC, Pelster G et al (2005) Magnetic resonance colonography for the detection of inflammatory diseases of the large bowel: quantifying the inflammatory activity. Gut 54:257–263CrossRefPubMed
15.
Zurück zum Zitat Punwani S, Rodriguez-Justo M, Bainbridge A et al (2009) Mural inflammation in Crohn disease: location-matched histologic validation of MR imaging features. Radiology 252:712–720CrossRefPubMed Punwani S, Rodriguez-Justo M, Bainbridge A et al (2009) Mural inflammation in Crohn disease: location-matched histologic validation of MR imaging features. Radiology 252:712–720CrossRefPubMed
16.
Zurück zum Zitat Rimola J, Rodriguez S, Garcia-Bosch O et al (2009) Magnetic resonance for assessment of disease activity and severity in ileocolonic Crohn’s disease. Gut 58:1113–1120CrossRefPubMed Rimola J, Rodriguez S, Garcia-Bosch O et al (2009) Magnetic resonance for assessment of disease activity and severity in ileocolonic Crohn’s disease. Gut 58:1113–1120CrossRefPubMed
17.
Zurück zum Zitat Salmon P, Shah R, Berg S, Williams C (1994) Evaluating customer satisfaction with colonoscopy. Endoscopy 26:342–346CrossRefPubMed Salmon P, Shah R, Berg S, Williams C (1994) Evaluating customer satisfaction with colonoscopy. Endoscopy 26:342–346CrossRefPubMed
18.
Zurück zum Zitat Taylor SA, Halligan S, Goh V et al (2003) Optimizing colonic distention for multi-detector row CT colonography: effect of hyoscine butylbromide and rectal balloon catheter. Radiology 229:99–108CrossRefPubMed Taylor SA, Halligan S, Goh V et al (2003) Optimizing colonic distention for multi-detector row CT colonography: effect of hyoscine butylbromide and rectal balloon catheter. Radiology 229:99–108CrossRefPubMed
19.
Zurück zum Zitat Tolan DJ, Greenhalgh R, Zealley IA, Halligan S, Taylor SA (2010) MR enterographic manifestations of small bowel Crohn disease. Radiographics 30:367–384CrossRefPubMed Tolan DJ, Greenhalgh R, Zealley IA, Halligan S, Taylor SA (2010) MR enterographic manifestations of small bowel Crohn disease. Radiographics 30:367–384CrossRefPubMed
20.
Zurück zum Zitat Furukawa A, Saotome T, Yamasaki M et al (2004) Cross-sectional Imaging in Crohn Disease. Radiographics 24:689–702CrossRefPubMed Furukawa A, Saotome T, Yamasaki M et al (2004) Cross-sectional Imaging in Crohn Disease. Radiographics 24:689–702CrossRefPubMed
21.
Zurück zum Zitat Gourtsoyiannis N, Papanikolaou N, Grammatikakis J, Papamastorakis G, Prassopoulos P, Roussomoustakaki M (2004) Assessment of Crohn’s disease activity in the small bowel with MR and conventional enteroclysis: preliminary results. Eur Radiol 14:1017–1024CrossRefPubMed Gourtsoyiannis N, Papanikolaou N, Grammatikakis J, Papamastorakis G, Prassopoulos P, Roussomoustakaki M (2004) Assessment of Crohn’s disease activity in the small bowel with MR and conventional enteroclysis: preliminary results. Eur Radiol 14:1017–1024CrossRefPubMed
22.
Zurück zum Zitat Maccioni F, Viscido A, Broglia L et al (2000) Evaluation of Crohn disease activity with magnetic resonance imaging. Abdom Imaging 25:219–228CrossRefPubMed Maccioni F, Viscido A, Broglia L et al (2000) Evaluation of Crohn disease activity with magnetic resonance imaging. Abdom Imaging 25:219–228CrossRefPubMed
24.
Zurück zum Zitat Landis JR, Koch GG (1997) The measurement of observer agreement for categorical data. Biometrics 33:159–174CrossRef Landis JR, Koch GG (1997) The measurement of observer agreement for categorical data. Biometrics 33:159–174CrossRef
25.
Zurück zum Zitat Chew CN, Nolan DJ, Jewell DP (1991) Small bowel gas in severe ulcerative colitis. Gut 32:1535–1537CrossRefPubMed Chew CN, Nolan DJ, Jewell DP (1991) Small bowel gas in severe ulcerative colitis. Gut 32:1535–1537CrossRefPubMed
26.
Zurück zum Zitat Lindgren SC, Flood LM, Kilander AF, Lofberg R, Persson TB, Sjodahl RI (1998) Early predictors of glucocorticosteroid treatment failure in severe and moderately severe attacks of ulcerative colitis. Eur J Gastroenterol Hepatol 10:831–835CrossRefPubMed Lindgren SC, Flood LM, Kilander AF, Lofberg R, Persson TB, Sjodahl RI (1998) Early predictors of glucocorticosteroid treatment failure in severe and moderately severe attacks of ulcerative colitis. Eur J Gastroenterol Hepatol 10:831–835CrossRefPubMed
27.
Zurück zum Zitat Langhorst J, Kuhle CA, Ajaj W et al (2007) MR colonography without bowel purgation for the assessment of inflammatory bowel diseases: diagnostic accuracy and patient acceptance. Inflamm Bowel Dis 13:1001–1008CrossRefPubMed Langhorst J, Kuhle CA, Ajaj W et al (2007) MR colonography without bowel purgation for the assessment of inflammatory bowel diseases: diagnostic accuracy and patient acceptance. Inflamm Bowel Dis 13:1001–1008CrossRefPubMed
28.
Zurück zum Zitat Horsthuis K, Bipat S, Stokkers PC, Stoker J (2009) Magnetic resonance imaging for evaluation of disease activity in Crohn’s disease: a systematic review. Eur Radiol 19:1450–1460CrossRefPubMed Horsthuis K, Bipat S, Stokkers PC, Stoker J (2009) Magnetic resonance imaging for evaluation of disease activity in Crohn’s disease: a systematic review. Eur Radiol 19:1450–1460CrossRefPubMed
29.
Zurück zum Zitat Sharman A, Zealley IA, Greenhalgh R, Bassett P, Taylor SA (2009) MRI of small bowel Crohn’s disease: determining the reproducibility of bowel wall gadolinium enhancement measurements. Eur Radiol 19:1960–1967CrossRefPubMed Sharman A, Zealley IA, Greenhalgh R, Bassett P, Taylor SA (2009) MRI of small bowel Crohn’s disease: determining the reproducibility of bowel wall gadolinium enhancement measurements. Eur Radiol 19:1960–1967CrossRefPubMed
30.
Zurück zum Zitat Horton KM, Corl FM, Fishman EK (2000) CT evaluation of the colon: inflammatory disease. Radiographics 20:399–418PubMed Horton KM, Corl FM, Fishman EK (2000) CT evaluation of the colon: inflammatory disease. Radiographics 20:399–418PubMed
31.
Zurück zum Zitat D’Haens G, Sandborn WJ, Feagan BG et al (2007) A review of activity indices and efficacy end points for clinical trials of medical therapy in adults with ulcerative colitis. Gastroenterology 132:763–86CrossRefPubMed D’Haens G, Sandborn WJ, Feagan BG et al (2007) A review of activity indices and efficacy end points for clinical trials of medical therapy in adults with ulcerative colitis. Gastroenterology 132:763–86CrossRefPubMed
32.
Zurück zum Zitat Cronin CG, Lohan DG, Browne AM, Roche C, Murphy JM (2010) Does MRI with oral contrast medium allow single-study depiction of inflammatory bowel disease enteritis and colitis? Eur Radiol [Epub ahead of print]PMID: 20069426 Cronin CG, Lohan DG, Browne AM, Roche C, Murphy JM (2010) Does MRI with oral contrast medium allow single-study depiction of inflammatory bowel disease enteritis and colitis? Eur Radiol [Epub ahead of print]PMID: 20069426
33.
Zurück zum Zitat Schoepfer AM, Beglinger C, Straumann A, Trummler M, Renzulli P, Seibold F, Ulcerative colitis (2009) Correlation of the Rachmilewitz endoscopic activity index with fecal calprotectin, clinical activity, C-reactive protein, and blood leukocytes. Inflamm Bowel Dis 15:1851–1858CrossRefPubMed Schoepfer AM, Beglinger C, Straumann A, Trummler M, Renzulli P, Seibold F, Ulcerative colitis (2009) Correlation of the Rachmilewitz endoscopic activity index with fecal calprotectin, clinical activity, C-reactive protein, and blood leukocytes. Inflamm Bowel Dis 15:1851–1858CrossRefPubMed
Metadaten
Titel
Derivation of a T2-weighted MRI total colonic inflammation score (TCIS) for assessment of patients with severe acute inflammatory colitis—a preliminary study
verfasst von
Rehana Hafeez
Shonit Punwani
Doug Pendse
Paul Boulos
Stuart Bloom
Steve Halligan
Stuart A. Taylor
Publikationsdatum
01.02.2011
Verlag
Springer-Verlag
Erschienen in
European Radiology / Ausgabe 2/2011
Print ISSN: 0938-7994
Elektronische ISSN: 1432-1084
DOI
https://doi.org/10.1007/s00330-010-1934-0

Weitere Artikel der Ausgabe 2/2011

European Radiology 2/2011 Zur Ausgabe

S3-Leitlinie zu Pankreaskrebs aktualisiert

23.04.2024 Pankreaskarzinom Nachrichten

Die Empfehlungen zur Therapie des Pankreaskarzinoms wurden um zwei Off-Label-Anwendungen erweitert. Und auch im Bereich der Früherkennung gibt es Aktualisierungen.

Fünf Dinge, die im Kindernotfall besser zu unterlassen sind

18.04.2024 Pädiatrische Notfallmedizin Nachrichten

Im Choosing-Wisely-Programm, das für die deutsche Initiative „Klug entscheiden“ Pate gestanden hat, sind erstmals Empfehlungen zum Umgang mit Notfällen von Kindern erschienen. Fünf Dinge gilt es demnach zu vermeiden.

„Nur wer sich gut aufgehoben fühlt, kann auch für Patientensicherheit sorgen“

13.04.2024 Klinik aktuell Kongressbericht

Die Teilnehmer eines Forums beim DGIM-Kongress waren sich einig: Fehler in der Medizin sind häufig in ungeeigneten Prozessen und mangelnder Kommunikation begründet. Gespräche mit Patienten und im Team können helfen.

Wie toxische Männlichkeit der Gesundheit von Männern schadet

08.04.2024 Andrologie Nachrichten

Stark, erfolgreich, allzeit belastbar – das sind Erwartungen, die Jungen und Männer von der Gesellschaft spüren. Das kann sie „toxisch“ werden lassen – und letztlich sogar der Gesundheit schaden, mahnt Dr. Dirk Sander von der Deutschen Aidshilfe.

Update Radiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.